Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Documentation of long-term data regarding ticagrelor use and evaluation of reasons for discontinuation of ticagrelor in patients with ACS

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: IHF GmbH - Institut für Herzinfarktforschung
• Treatments: Ticagrelor

Criteria

Inclusion Criteria:

• Age > 18

• ACS (STEMI or NSTE-ACS) with PCI

• Ticagrelor treatment during the acute phase

• Written informed consent for participation in the study.

Exclusion Criteria:

• None